SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-031323
Filing Date
2008-05-08
Accepted
2008-05-08 16:41:52
Documents
8
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-11200_110q.htm 10-Q 687610
2 EX-10.4 a08-11200_1ex10d4.htm EX-10.4 165462
3 EX-10.37 a08-11200_1ex10d37.htm EX-10.37 53572
4 EX-10.38 a08-11200_1ex10d38.htm EX-10.38 51488
5 EX-10.39 a08-11200_1ex10d39.htm EX-10.39 51542
6 EX-31.1 a08-11200_1ex31d1.htm EX-31.1 13886
7 EX-31.2 a08-11200_1ex31d2.htm EX-31.2 14860
8 EX-32 a08-11200_1ex32.htm EX-32 11575
  Complete submission text file 0001104659-08-031323.txt   1051479
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 08814582
SIC: 2834 Pharmaceutical Preparations